Key facts
- This page summarizes Hundzinski Ronald T.'s Form 4 filing for InfuSystem Holdings, Inc (INFU).
- 1 reported transaction and 1 derivative row are listed below.
- Accepted by SEC: 14 May 2026, 18:45.
Hundzinski Ronald T. - 12 May 2026 Form 4 Insider Report for InfuSystem Holdings, Inc (INFU)
- Reporting relationship
- Director
- Issuer ticker
- INFU
- Reported as of
- 12 May 2026
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 14 May 2026, 18:45:05 UTC
- Prior SEC filing
- 20 May 2025
- Next SEC filing
- 15 May 2026
- Source filing
- View source filing
- Reporting owner signature
- /s/ Kevin Whitman, Attorney-in-Fact for Ronald T. Hundzinski
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Hundzinski Ronald T. filed Form 4 for InfuSystem Holdings, Inc (INFU) on 14 May 2026.
Change
- Previous filing in this sequence was filed on 20 May 2025.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reporting Owners (1)
CIK 0001488024
Primary reporting owner
Hundzinski Ronald T
- Relationship
- Director
- Address
- C/O INFUSYSTEM HOLDINGS, INC., 3851 WEST HAMLIN ROAD, ROCHESTER HILLS
- Signature
- /s/ Kevin Whitman, Attorney-in-Fact for Ronald T. Hundzinski
- Signature date
- 14 May 2026
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
INFU
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 5,000
- Date
- 12 May 2026
- Ownership
- Direct
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
INFU
transaction
Derivative
Stock Option (right to buy)
Award
- Transaction value
- Shares
- +24,890
- Change %
- Price
- $0.000000*
- Shares after
- 24,890
- Date
- 12 May 2026
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 24,890
- Exercise price
- $8.37
- Footnotes
- F1
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 1 footnote
Footnote F1
The option, representing the right to purchase 24,890 shares of InfuSystem Holdings, Inc. common stock, vests on May 12, 2027.